An unprecedented anti-aging vaccine is under development in Russia, aiming to increase human lifespan beyond 150 years. This is a gene therapy focused on blocking the RAGE receptor, which controls the aging process in cells. Russia’s Deputy Science Minister Denis Seski revealed this project. Under the leadership of President Vladimir Putin, a massive budget of approximately $26.4 billion is being spent on this national project named ‘New Technologies for Health Preservation’.
This mega-project launched by the Russian government has created a significant stir in the field of global medical science. Its main objective is to halt the human aging process and increase the average lifespan to 150 years.
What is the RAGE Receptor and How Does it Work ? – The core aim of this cellular gene therapy is to block or deactivate RAGE (Receptor for Advanced Glycation Endproducts) within the body’s cells.
Cause of Aging – As humans age, harmful proteins and molecules accumulate in the body, binding with the RAGE receptor and causing inflammation and oxidative stress within cells.
Role of the Vaccine – Through this gene therapy, RAGE signaling will be shut down, preventing rapid cellular damage and significantly slowing down the aging process. Additionally, it will reduce the risk of serious age-related diseases like Alzheimer’s, heart disease, and diabetes.
Budget and Government Efforts
Heavy Investment – The Russian government has allocated a budget of over $26.4 billion (approximately 2.2 lakh crore rupees) for this national project, ‘New Technologies for Health Preservation’.
Political Will – This project is receiving top priority under the direction of President Vladimir Putin. According to Russia’s Deputy Science Minister Denis Seski, the country’s top scientists, geneticists, and medical research institutes are engaged in this work.
Scientific Challenges and Global Reaction – Although this research seems extremely promising, several global scientists have raised questions about it.
Safety and Side Effects- The impact of modifying genetics on the body’s immune system is not yet clear.
Testing Phase – Currently, this technology is at the laboratory and preliminary testing stages. Its successful application in humans and final approval may require several more years of clinical trials.
If this project is successful, it will completely transform not just Russia, but the lifestyle and history of medical science for all of humanity.
